[{"id":"a25a7657-8064-40e7-806c-f6d355167a9b","acronym":"","url":"https://clinicaltrials.gov/study/NCT05042531","created_at":"2021-09-13T14:55:55.634Z","updated_at":"2024-07-02T16:36:11.575Z","phase":"","brief_title":"Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia","source_id_and_acronym":"NCT05042531","lead_sponsor":"LanZhou University","biomarkers":" TP53 • CDH1 • CASP3 • DNMT1 • CASP8 • DNMT3B • CDKN1A","pipe":"","alterations":" ","tags":["TP53 • CDH1 • CASP3 • DNMT1 • CASP8 • DNMT3B • CDKN1A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dasatinib • azacitidine"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 11/13/2021","start_date":" 11/13/2021","primary_txt":" Primary completion: 09/01/2023","primary_completion_date":" 09/01/2023","study_txt":" Completion: 12/15/2023","study_completion_date":" 12/15/2023","last_update_posted":"2022-04-25"},{"id":"88850ac0-142f-4f2d-8c74-9f006d0da523","acronym":"","url":"https://clinicaltrials.gov/study/NCT03877159","created_at":"2021-01-18T19:06:45.018Z","updated_at":"2024-07-02T16:36:42.936Z","phase":"","brief_title":"Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma","source_id_and_acronym":"NCT03877159","lead_sponsor":"Guy's and St Thomas' NHS Foundation Trust","biomarkers":" CASP8","pipe":"","alterations":" ","tags":["CASP8"],"overall_status":"Unknown status","enrollment":" Enrollment 100","initiation":"Initiation: 11/11/2017","start_date":" 11/11/2017","primary_txt":" Primary completion: 01/30/2021","primary_completion_date":" 01/30/2021","study_txt":" Completion: 01/30/2021","study_completion_date":" 01/30/2021","last_update_posted":"2020-07-22"},{"id":"4b450905-2455-4349-a4a1-b03f107d421e","acronym":"","url":"https://clinicaltrials.gov/study/NCT01440413","created_at":"2022-05-29T05:55:16.136Z","updated_at":"2024-07-02T16:36:47.778Z","phase":"","brief_title":"Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer","source_id_and_acronym":"NCT01440413","lead_sponsor":"Centre Leon Berard","biomarkers":" HMGB1 • CASP8","pipe":"","alterations":" ","tags":["HMGB1 • CASP8"],"overall_status":"Unknown status","enrollment":" Enrollment 40","initiation":"Initiation: 12/01/2011","start_date":" 12/01/2011","primary_txt":" Primary completion: 12/01/2018","primary_completion_date":" 12/01/2018","study_txt":" Completion: 12/01/2020","study_completion_date":" 12/01/2020","last_update_posted":"2020-03-24"}]